Skip to main content
Premium Trial:

Request an Annual Quote

Instead of Tearing Your Hair Out

There are two reasons why an experiment may not be working, Dr. Isis tells one of her readers who wrote in. First, she says is that you're just not doing it right and for that, she suggests reaching out to someone who has done something similar. "You've simply got to find the person who can help you do what you need," she says. The second reason is that your methods are fine — you just aren't getting the expected results. To determine that your results are reliable she says you must consider if you've done the proper controls and determine of someone else can reproduce your results. "At the end of the day when I could say "yes" to both questions, I had to conclude that my results were reliable, Isis writes."In the end, the results opened up a much more interesting door than I would have expected."

In the comment section of Dr. Isis's blog, Comrade PhysioProf adds "a third — and potentially most important — possibility, which is that what one is trying to do just ain't gonna work no matter what (i.e., yield reliable interpretable results), for reasons that will never become apparent."

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.